ArticleTherapeutics and clinical risk management2012
Coronary artery disease in Africa and the Middle East.
Article in Therapeutics and clinical risk management, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 45 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
Potential Drug Interactions With Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.
- Women in Saudi Arabia and the Prevalence of Cardiovascular Risk Factors: A Systematic Review.Journal of environmental and public health · 2016Pooled it
- Expert consensus on Lipoprotein(a) in the Gulf countries: Navigating cardiovascular risk and therapeutic advances.Atherosclerosis plus · 2026Article
- Association between cardiorespiratory fitness levels and cardiometabolic risk factors among metropolitan police officers: a cross-sectional study.BMC public health · 2026Article
- Utilization of evidence-based secondary preventive therapies post-acute coronary syndrome: a heart registry cohort study in Kenya.The Pan African medical journal · 2026Article
- Assessment of Risk Factors Associated With Coronary Artery Disease (CAD) in the Western Libyan Patients.Cardiovascular therapeutics · 2025Article
- Barriers to and facilitators of physical activity among Saudi adults: a qualitative study.Frontiers in psychology · 2025Article
- Knowledge, attitude and practice towards physical activity among healthcare students at a public university in Saudi Arabia.Frontiers in public health · 2024Article
- Factors Associated with Sedentary Behavior and Physical Activity Among People Living in Saudi Arabia - A Cross-Sectional Study.Risk management and healthcare policy · 2023Article
- Evaluation of Young Adults' Physical Activity Status and Perceived Barriers in the Riyadh Region of Saudi Arabia.Journal of multidisciplinary healthcare · 2023Article
- Article
- Risk Factors for Coronary Heart Disease Among Lebanese Women: A Case-Control Study.Vascular health and risk management · 2022Article
- Knowledge on added sugar content in food labels among adult out-patient clinic visitors at a tertiary care teaching hospital, Riyadh, KSA.Bioinformation · 2022Article
- Analysis of mutations in leu tRNA gene in patients of heart diseases.Saudi journal of biological sciences · 2022Article
- Distributions and burden of coronary calcium in asymptomatic Saudi patients referred to computed tomography.International journal of cardiology. Heart & vasculature · 2021Article
- Obesity, Lifestyle Behaviors, and Dietary Habits of Saudi Adolescents Living in Riyadh (ATLS-2 Project): Revisited after a Ten-Year Period.Life (Basel, Switzerland) · 2021Article
- Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review.Journal of epidemiology and global health · 2021Review
- An Emerging Syndemic of Smoking and Cardiopulmonary Diseases in People Living with HIV in Africa.International journal of environmental research and public health · 2021Article
- Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy.BMC cardiovascular disorders · 2020Article
- Self-reported sleep quality and depression in post myocardial infarction patients attending cardiology outpatient clinics in Oman.International journal of nursing sciences · 2019Article
- Low Protein Z Level: A Thrombophilic Risk Biomarker for Acute Coronary Syndrome.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Countries in Africa and the Middle East bear a heavy burden from cardiovascular disease. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Patients in Africa and the Middle East present with myocardial infarction at a younger age, on average, compared with patients elsewhere. The projected future burden of mortality from coronary heart disease in Africa and the Middle East is set to outstrip that observed in other geographical regions. Recent detailed nationally representative epidemiological data are lacking for many countries, and high proportions of transient expatriate workers in countries such as Saudi Arabia and the United Arab Emirates complicate the construction of such datasets. However, the development of national registries in some countries is beginning to reveal the nature of coronary heart disease. Improving lifestyles (reducing calorie intake and increasing physical activity) in patients in the region will be essential, although cultural and environmental barriers will render this difficult. Appropriate prescribing of pharmacologic treatments is essential in the prevention and management of cardiovascular disease. In particular, recent controversies relating to the therapeutic profile of beta-blockers may have reduced their use. The current evidence base suggests that beta-blockers are as effective as other therapies in preventing cardiovascular disease and that concerns relating to their use in hypertension and cardiovascular disease have been overstated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.